Financhill
Back

DaVita Quote, Financials, Valuation and Earnings

DaVita Price Quote

$151.98
+0.13 (+3.01%)
(Updated: December 21, 2024 at 5:23 AM ET)

DaVita Key Stats

Buy
62
DaVita (DVA) is a Buy

Day range:
$147.58 - $153.47
52-week range:
$103.40 - $169.52
Dividend yield:
0%
P/E ratio:
20.47
P/S ratio:
1.07
P/B ratio:
32.21%

Volume:
1.7M
Avg. volume:
781.3K
1-year change:
46.19%
Market cap:
$12.5B
Revenue:
$12.1B
EPS:
$9.27

How Much Does DaVita Make?

Data Unavailable

Is DaVita Growing As A Company?

Data Unavailable

DaVita Stock Price Performance

  • Did DaVita Stock Go Up Last Month?
    DaVita share price went down by -5.92% last month
  • Did DVA's Share Price Rise Over The Last Year?
    DVA share price rose by 46.19% over the past 1 year

What Is DaVita 52-Week High & Low?

  • What Is DaVita’s 52-Week High Share Price?
    DaVita has traded as high as $169.52 over the past 52 weeks
  • What Is DaVita’s 52-Week Low Share Price?
    DaVita has traded as low as $103.40 over the past 52 weeks

DaVita Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy DaVita?

Data Unavailable

Is DaVita Cash Flow Positive?

Data Unavailable

DaVita Return On Invested Capital

Data Unavailable

DaVita Earnings Date & Stock Price

  • What Is DaVita's Stock Price Today?
    A single share of DVA can be purchased today for 151.85
  • What Is DaVita’s Stock Symbol?
    DaVita trades on the S&P500 under the ticker symbol: DVA
  • When Is DaVita’s Next Earnings Date?
    The next quarterly earnings date for DaVita is scheduled on February 13, 2025
  • When Is DVA's next ex-dividend date?
    DaVita's next ex-dividend date is December 22, 2024
  • How To Buy DaVita Stock?
    You can buy DaVita shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

DaVita Competitors

  • Who Are DaVita's Competitors?
    Below is a list of companies who compete with DaVita or are related in some way:
    • Baxter International Inc (BAX)
    • Boston Scientific Corp (BSX)
    • Quest Diagnostics Inc (DGX)
    • Encompass Health Corp (EHC)
    • HCA Healthcare Inc (HCA)

DaVita Dividend Yield

Data Unavailable

DaVita Analyst Estimates

YoY Growth Past Surprise
EPS: -4.58% -4.94%
Revenue: 4.56% 0.5%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 6
Sell Recommendations: 0
Price Target: 148.44
Downside from Last Price: -2.25%

Major Shareholders

Data Unavailable